Amneal Pharmaceuticals, Inc. initiated the U.S. commercialization of TEPADINA® (thiotepa) for Injection 200 mg in a patented multichambered bag. This new “Lyobag” presentation, developed and manufactured by ADIENNE Pharma & Biotech SA, a Swiss-based biopharmaceutical company focused on oncology and rare diseases, was FDA approved, for the same four indications as the existing vial pre... https://www.coherentmarketinsights.com/news/multichambered-bag-for-oncology-with-tepadinar-thiotepa-200-mg-launched-by-amneal-pharmaceuticals-1462